The Brazilian Society of Surgical Oncology (SBCO) Guidelines for the Treatment of Exocrine Pancreatic Insufficiency in Cancer Patients

Exocrine pancreatic insufficiency (EPI) in oncology patients requires careful attention due to its clinical significance and frequent underdiagnosis. This narrative review and Guideline established by the Brazilian Society of Surgical Oncology suggest a practical approach to diagnosis and pancreatic enzyme replacement therapy (PERT). This promising approach can improve symptoms, nutritional status, and quality of life, potentially positively impacting survival in unresectable pancreatic cancer and postsurgical settings.

Authors

Institutions

Publication Details

Journal
Journal of Surgical Oncology
Published
2025-05-26
DOI
https://doi.org/10.1002/jso.28162
Citations
1
Primary Topic
Pancreatic and Hepatic Oncology Research
Type
article
Field-Weighted Citation Impact
1.05
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

The Brazilian Society of Surgical Oncology (SBCO) Guidelines for the Treatment of Exocrine Pancreatic Insufficiency in Cancer Patients

Fernando E. Cruz Felippe, Felipe Henning Gaia Duarte, Pedro Eder Portari Filho, Heládio Feitosa e Castro Neto et al.
1 citations
Journal of Surgical Oncology
Pancreatic and Hepatic Oncology Research
1.05
article

The Brazilian Society of Surgical Oncology (SBCO) Guidelines for the Treatment of Exocrine Pancreatic Insufficiency in Cancer Patients

Fernando E. Cruz Felippe, Felipe Henning Gaia Duarte, Pedro Eder Portari Filho, Heládio Feitosa e Castro Neto, Marcos Gonçalves Adriano, Flávio Daniel Saavedra Tomasich, Anelisa K. Coutinho, Rodrigo Nascimento Pinheiro, Felipe José Fernández Coimbra, Rafael Albagli, Alexandre Menezes de Brito, Alexandre Ferreira Oliveira
article en
1 citations

Abstract

Exocrine pancreatic insufficiency (EPI) in oncology patients requires careful attention due to its clinical significance and frequent underdiagnosis. This narrative review and Guideline established by the Brazilian Society of Surgical Oncology suggest a practical approach to diagnosis and pancreatic enzyme replacement therapy (PERT). This promising approach can improve symptoms, nutritional status, and quality of life, potentially positively impacting survival in unresectable pancreatic cancer and postsurgical settings.

Journal of Surgical OncologyVol. 132(1)
Universidade Federal de Juiz de Fora (BR), Gaertner (United States) (US), Brazilian Computer Society (BR), AC Camargo Hospital (BR), Hospital Universitário Gaffrée e Guinle (BR), Hospital de Câncer de Barretos (BR), Hospital Erasto Gaertner (BR), Hospital Araújo Jorge (BR), Hospital Haroldo Juaçaba (BR), Society of Surgical Oncology (US), Instituto Nacional de Câncer - INCA (BR), Universidade Salvador (BR), Universidade Federal do Estado do Rio de Janeiro (BR)
Zero hunger
Openalex Percentile: Top 22%
Pancreatic and Hepatic Oncology Research
1.05
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.